PTC-589
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PTC-589, covering 2022-05-03 to 2022-05-03. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Biomarker Study of PTC-589 in Participants With Parkinson's Disease [Phase 2]